GOG-0182 trial

The GOG-0182 trial was a clinical study evaluating whether adding the drug pazopanib to standard chemotherapy improves outcomes for women with advanced ovarian or fallopian tube cancers. Participants received chemotherapy alone or with pazopanib to see if the combined treatment better controlled the cancer and increased survival. The trial aimed to determine if pazopanib could be an effective addition to existing treatments, potentially offering improved prognosis for patients facing these types of cancers.